The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
about
Interventions for reducing inflammation in familial Mediterranean feverHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative ReviewNaturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1β.Familial Mediterranean Fever developing in a Japanese kidney transplant recipientPotential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signalsWhy not treat human cancer with interleukin-1 blockade?Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAn expanding role for interleukin-1 blockade from gout to cancer.Autoinflammation: translating mechanism to therapy.Cytokine levels in the serum of healthy subjectsEfficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.NOD-like receptors and inflammation.Treating inflammation by blocking interleukin-1 in humans.Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for ManagementFamilial Mediterranean fever--a review.Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature.The emerging role of interleukin-1β in autoinflammatory diseases.Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.IL-1β biological treatment of familial Mediterranean fever.Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.Canakinumab Investigated for Treating Familial Mediterranean Fever.Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.Non-response to colchicine in familial Mediterranean fever should be identified accurately.Familial Mediterranean fever: the first adult case in Korea.A child with recurrent episodes of fever and joint pain.
P2860
Q24187197-C6FF5BAC-2044-417A-A980-F9D045523BDBQ24631660-6E5FB857-4C89-41D4-91B5-9DED84E2DA59Q26768281-76682A75-1E6E-4BBF-B143-B768D993B1CDQ30419673-E56DD446-BDEE-417B-BBD4-B495390068F9Q33622298-1C230226-5759-4D4C-AE36-E7820150DB75Q33710807-3906FD4D-4843-4ECD-B753-25910C721A85Q33798590-BAB78C9E-4267-48E2-AB08-E78A82E11C0DQ33833871-A12E1475-AB38-4F83-B327-D81ECAB33FACQ34608120-F4D05A4B-F011-49FD-9811-6B8F17B53149Q35086225-047A10E1-F2E1-40A2-981F-3A5961A7C27EQ35133812-24A614A2-115B-4CA7-AE3E-7A54EF5C17F1Q35219001-F5C8AA2E-CA46-429F-95F2-475A71087ED3Q35558406-47DB8FDF-4ACA-439F-80B2-65C406C0C28CQ36711758-099F2A1A-ADFE-478D-A641-F5E8CB22C2C6Q36798016-84F4321B-837B-4464-B3B9-633E556C2A81Q36816872-580FA8A8-60B2-437B-8BC7-6123EA66196BQ37270409-99EA8BF4-980B-4B89-80CA-FADF7A1C93EFQ37353179-03B8B38B-5272-495D-A09D-9FCBE7DF8B09Q37636664-0E940829-4D7D-4ED7-BB77-51B32E6AF8F8Q37716794-15ECF8C9-1B29-439F-9DD6-01815C87FBDFQ37847929-C60E5674-DC3B-4EFC-B2C6-E3A7EF7C2C81Q37874985-63580F46-8F35-4EAA-A7A0-5E94D4CC523DQ37897494-40023C5A-913A-4903-9F77-E64966C887F9Q37979862-0EBE70CB-83FF-4321-B52C-547508415286Q38004932-20DE1BCE-14A2-4121-862E-5665F941A0B0Q38074355-FEC51E36-BF8D-4E47-8CE1-B7C9058291E8Q38122566-4372D4B6-215B-433B-A831-512B4098277CQ38151758-4EBEC0A9-FC2E-4CBD-83B2-E91B3B0FA0E2Q40089782-A3CF969E-5948-4CC3-BD36-128AFE39A473Q40172573-5C8B4B9E-C7A7-4141-88FE-EEF9F6BCF6BFQ40176934-F89DFAE6-F3CB-4F45-8286-40CAFF9B6B5DQ40211562-D216A422-B1EF-4414-B97E-4262DDFA243BQ40267495-FBD80AB1-7E34-4672-AE59-75F50800F710Q40408126-7CDEB5B4-FF5C-4A9A-A205-3EA5D83E833D
P2860
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The efficacy of anakinra in an ...... t familial Mediterranean fever
@ast
The efficacy of anakinra in an ...... t familial Mediterranean fever
@en
The efficacy of anakinra in an ...... t familial Mediterranean fever
@nl
type
label
The efficacy of anakinra in an ...... t familial Mediterranean fever
@ast
The efficacy of anakinra in an ...... t familial Mediterranean fever
@en
The efficacy of anakinra in an ...... t familial Mediterranean fever
@nl
prefLabel
The efficacy of anakinra in an ...... t familial Mediterranean fever
@ast
The efficacy of anakinra in an ...... t familial Mediterranean fever
@en
The efficacy of anakinra in an ...... t familial Mediterranean fever
@nl
P2860
P3181
P1476
The efficacy of anakinra in an ...... t familial Mediterranean fever
@en
P2093
Alberto Tommasini
Lorenzo Calligaris
P2860
P2888
P304
P3181
P356
10.1007/S00431-007-0547-3
P407
P577
2007-06-23T00:00:00Z
P5875
P6179
1012972595